What does peer-reviewed research say about these claims?

Bro translation: Mainstream evidence supports chiropractic and physical therapy for selected musculoskeletal pain and rehabilitation, but it does not support chiropractic as a treatment for neuropathy as a root-cause disease strategy or as a way to reliably improve blood pressure, digestion, sleep, or heart-rate variability through alignment. The pregnancy claim is also overstated: the literature does not justify presenting Webster Technique as a proven way to ensure complication-free birth or meaningfully cut labor time in the general case.

Is Dr Amelia Rodrock a real medical doctor?

Amelia Rodrock is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Is the claim "Neuropathy" supported by medical literature?

The influencer’s claim is extremely vague (“Neuropathy”) and does not specify any particular intervention, mechanism, or recommendation. From the indexed papers, the only directly relevant items are those dealing with diabetic peripheral neuropathy and painful diabetic neuropathy. One indexed review discusses the epidemiology and expansion of diabetic peripheral neuropathy in African populations, supporting that diabetic neuropathy is a common, clinically important complication of diabetes with substantial burden, including pain, sensory loss, and disability . Another indexed review is an appraisal of a systematic review and network meta-analysis on pregabalin dosing for painful diabetic neuropathy, confirming that pregabalin is an established first-line pharmacologic option and that dose optimization (typically 300–600 mg/day) improves pain outcomes in painful diabetic neuropathy . Major guidelines and meta-analyses retrieved in academic search consistently state that duloxetine and pregabalin are first-line pharmacologic treatments for painful diabetic peripheral neuropathy, based on multiple randomized controlled trials, with modest but statistically significant pain reduction and improvements in quality of life, sleep, and function. This supports the general idea that neuropathic pain in diabetes is treatable with evidence-based medications and that standardized guideline-based management exists. Because the claim is simply the word “Neuropathy” with no specific assertion, recommendation, or mechanism, high-quality evidence cannot be said to either support or contradict it directly. The indexed evidence does, however, contradict any implication that neuropathy (especially diabetic peripheral neuropathy) is either rare, untreatable, or unsupported by rigorous evidence. Meta-analyses and guidelines show that neuropathy is common in diabetes, has well-characterized epidemiology, and responds to pharmacologic and nonpharmacologic interventions, although the magnitude of benefit is often modest and adverse effects are common. A meta-epidemiological analysis of pregabalin trials for neuropathic pain has shown that the drug’s effect size versus placebo is small and often below the minimum clinically important difference, suggesting that while pregabalin is statistically effective, clinical benefit may be limited and has decreased over time; this would contradict overly strong claims that neuropathy can be dramatically or consistently reversed just with pregabalin or similar drugs. Overall, any influencer claim that neuropathy is either trivial, easily cured, or unsupported by mainstream medicine would be at odds with the available evidence. The mainstream medical position is that neuropathy is a broad category of disorders involving damage or dysfunction of peripheral or central nerves, with multiple causes including diabetes, metabolic disease, autoimmune conditions, toxic exposures (such as chemotherapy), infections, and hereditary disorders. For diabetic peripheral neuropathy specifically, large epidemiologic reviews and guidelines consider it one of the most frequent chronic complications of diabetes, often presenting as painful diabetic peripheral neuropathy and associated with substantial impairment, risk of foot ulceration, and reduced quality of life . Mainstream guidelines (e.g., American Academy of Neurology, American Diabetes Association, European and UK guideline bodies) recommend a structured approach: tight but safe glycemic control for diabetic neuropathy; systematic evaluation for reversible causes (e.g., B12 deficiency, thyroid disease, toxins); and evidence-based pharmacologic treatment of painful diabetic neuropathy with first-line agents such as duloxetine and pregabalin, and often gabapentin or tricyclic antidepressants, supported by multiple randomized controlled trials and meta-analyses . Nonpharmacologic strategies, including foot care, physical therapy, psychological support, and in selected cases neuromodulation (e.g., spinal cord stimulation), also have evidence of benefit. The mainstream view is that neuropathy is common, clinically important, and only partly reversible; treatments primarily aim to reduce pain, prevent complications, and improve function, rather than “cure” established nerve damage. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: unsupported.

Is the claim "physical therapy" supported by medical literature?

High-quality evidence supports that physical therapy (physiotherapy) is an effective component of rehabilitation and symptom management for many conditions, though effects are often small to moderate and condition-specific. A systematic review of early physical therapy for acute low back pain found that early PT versus non-PT care produced statistically significant short‑term reductions in pain and disability, with small effect sizes, showing benefit over usual care without PT.[20] A randomized controlled trial in chronic low back pain showed that a combination of physical therapy methods with exercise and medical treatment improved pain and functional status more than exercise plus medical treatment alone, supporting PT as an additive benefit.[15] Systematic review evidence for chronic low back pain suggests exercise therapy and multidisciplinary treatments including physiotherapy can reduce pain and disability versus usual care or no treatment, though overall evidence quality is low to moderate.[18] In stroke rehabilitation, a large Cochrane-style systematic review including hundreds of randomized controlled trials shows that specific physical rehabilitation approaches (e.g., task-specific training, intensive therapy) improve motor function and gait velocity in the short to medium term, supporting physical therapy as a core element of stroke recovery.[3] Physical therapy–involved physical activity interventions for adults with neurologic conditions produce small but significant improvements in physical activity, with stronger effects when combined with behavior-change techniques, indicating PT can effectively promote activity and related functional gains.[25] The index systematic review protocol for secondary lymphoedema after breast cancer reflects that PT interventions are considered sufficiently promising and important to warrant a network meta-analysis, consistent with PT being an accepted therapeutic modality in oncology rehabilitation, even though definitive comparative effectiveness results are still in progress.[0] For congenital muscular torticollis, a systematic review informing clinical practice guidelines concludes that physical therapy management is central and effective in improving neck range of motion and reducing deformity, which underpins guideline recommendations.[3] Blood-flow restriction training (BFRT), a specific physical therapy modality in knee osteoarthritis, has been studied in RCT-based systematic reviews and meta-analyses; several analyses show that BFRT yields improvements in strength and function comparable to conventional resistance training, with some low- to moderate-certainty evidence that it can improve functionality and knee extension strength similarly to high-intensity resistance training, supporting BFRT as a viable PT technique when heavy loads are not tolerated.[6][22][19] Although physical therapy is widely used and often beneficial, high-quality evidence reveals important limitations, heterogeneity, and areas where benefits are modest or uncertain. For chronic low back pain, a systematic review shows that while exercise therapy and multidisciplinary treatment can reduce pain and disability versus usual care or no treatment, the overall level of evidence is low, and data are insufficient to draw firm conclusions for several commonly used PT modalities such as massage, traction, superficial heat/cold, low-level laser, lumbar supports, and back schools, indicating that not all physical therapy techniques have robust support.[18] In acute low back pain, early physical therapy versus delayed PT does not show clear long‑term benefit in pain or disability, suggesting timing of PT may have limited impact beyond short-term outcomes.[20] In pediatric oncology, a Cochrane-style review found no randomized controlled trials comparing physical therapy interventions focused on symptom relief and compensation for therapy-related side effects, and concluded that current evidence is inadequate to inform clinical practice in children and adolescents with cancer, highlighting a major evidence gap.[5] For stroke, evidence for physical rehabilitation versus attention control is very uncertain for several functional outcomes, indicating that not all PT approaches are clearly superior to non-specific attention and that better trials are needed.[3] Blood-flow restriction training in knee osteoarthritis illustrates how specific PT modalities can be weakly supported or contested: multiple systematic reviews and meta-analyses report low to moderate quality evidence that BFRT does not meaningfully enhance symptom outcomes compared with traditional resistance training, and that any short‑term pain benefits are of questionable clinical relevance, with overall low certainty and weak recommendations for its routine use.[7][11][13][16][17][21][19] Many physical therapy clinical trials have a high risk of bias and poor reporting of intervention details, which undermines the strength and reproducibility of the evidence base and complicates translation into practice.[8][25] Overall, evidence often supports PT as beneficial, but not universally or strongly for every condition or technique, and exaggerated claims that physical therapy is highly effective for all problems or dramatically superior to other evidence‑based interventions are not supported by current high‑quality data. The mainstream medical and scientific position is that physical therapy is an evidence‑based, core component of rehabilitation and symptom management for a wide range of musculoskeletal, neurologic Literature verdict: mixed.

Amelia Rodrock fact-check: neuropathy (Dr Amelia Rodrock)

https://web.archive.org/web/20240613100534/https://chirorock.com/amelia-rodrock-chiropractor/

View dossier →

Bottom line

Funnel-first framing that runs on persuasion, light on published evidence.

Of 18 health claims, 10 run counter to or conflict with the published evidence, and 8 were not independently checked.
Primary persuasion tactic: Broad medical authority from narrow licenses.
Stated credentials look inflated relative to the advice given.
Profits from the products and labs they recommend, with no clear disclosure.
Gives advice beyond what their license covers.

Dr. Trust Me Bro says

Jeremy Rodrock and Amelia Rodrock are serving up the full glossy clinic package: doctor-title sheen, testimonial confetti, and enough 'holistic' language to make a spine adjustment sound like a full-system reboot. The best part is the broadened menu of neuropathy, pregnancy, and physiology promises — because why stop at backs when you can market a whole-body miracle?

83/100

High grift signals

8 critical2 high0 medium0 low

Score breakdown

40/100

Credentials

The title on the marquee is doing more work than the credential behind it. This doc bro is selling a bigger doctor than they can actually back up.

82/100

Manipulation

The site uses root-cause framing, repeated testimonials, and outcome-heavy language about birth and systemic physiology without a disclaimer; that’s a polished persuasion stack aimed at making broad claims feel clinically inevitable.

83/100

Sales funnel

A $49 new-patient special, a report-of-findings flow, digital X-rays/diagnostic testing, and ongoing care-plan language create a classic appointment-to-treatment revenue funnel, even without supplements or affiliate links.

40/100

Grift map

Few outbound commerce links detected.

40/100

Evidence gap

2 of 5 literature-checked claims unsupported.

62/100

Bro energy

This is standard clinic-bro territory rather than full influencer grift: the title, testimonials, and expansive health claims do the promotion, but there’s no affiliate army or supplement empire visible here.

Direct answer

Amelia Rodrock is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. §65-2871 (Kansas Healing Arts Act)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating neuropathy, physical therapy, Neuropathy 'root cause' treatment, and Physiology optimization through alignment, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward paid programs that Amelia Rodrock profits from.

Key findings

False Authority: The page presents Jeremy Rodrock and Amelia Rodrock as doctors while marketing diagnosis and treatment for systemic problems like neuropathy, pregnancy-related labor outcomes, and physiologic optimization. That borrows the prestige of a doctor title to imply broader medical…see section ↓
Claim "Neuropathy": not supported by peer-reviewed evidence.see section ↓
Claim "physical therapy": mixed in the medical literature.see section ↓
NPI registry confirms AMELIA RODROCK as Chiropractor (DC) in Kansas (NPI 1790107894).see section ↓
Amelia Rodrock shows credential inflation relative to stated vs likely credentials.see section ↓
Dr Amelia Rodrock is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. §65-2871 (Kansas Healing Arts Act)), these advertised activities appear outside Amelia Rodrock's license (including conditions they merely list as ones they treat): neuropathy, physical therapy, We don’t just treat…see section ↓
12 of 22 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓

Claims & evidence

12 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.

Outside scopeListed service

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure neuropathy.

neuropathy

Supports: The influencer’s claim is extremely vague (“Neuropathy”) and does not specify any particular intervention, mechanism, or recommendation. From the indexed papers, the only directly relevant items are those dealing with diabetic peripheral neuropathy and painful diabetic neuropathy. One indexed review discusses the epidemiology and expansion of diabetic peripheral neuropathy in African populations, supporting that diabetic neuropathy is a common, clinically important complication of diabetes with substantial burden, including pain, sensory loss, and disability . ^[4] Another indexed review is an appraisal of a systematic review and network meta-analysis on pregabalin dosing for painful diabetic neuropathy, confirming that pregabalin is an established first-line pharmacologic option and that dose optimization (typically 300–600 mg/day) improves pain outcomes in painful diabetic neuropathy . ^[2]^[3] Major guidelines and meta-analyses retrieved in academic search consistently state that duloxetine and pregabalin are first-line pharmacologic treatments for painful diabetic peripheral neuropathy, based on multiple randomized controlled trials, with modest but statistically significant pain reduction and improvements in quality of life, sleep, and function. ^[1] This supports the general idea that neuropathic pain in diabetes is treatable with evidence-based medications and that standardized guideline-based management exists.
Contradicts: Because the claim is simply the word “Neuropathy” with no specific assertion, recommendation, or mechanism, high-quality evidence cannot be said to either support or contradict it directly. The indexed evidence does, however, contradict any implication that neuropathy (especially diabetic peripheral neuropathy) is either rare, untreatable, or unsupported by rigorous evidence. Meta-analyses and guidelines show that neuropathy is common in diabetes, has well-characterized epidemiology, and responds to pharmacologic and nonpharmacologic interventions, although the magnitude of benefit is often modest and adverse effects are common. ^[4] A meta-epidemiological analysis of pregabalin trials for neuropathic pain has shown that the drug’s effect size versus placebo is small and often below the minimum clinically important difference, suggesting that while pregabalin is statistically effective, clinical benefit may be limited and has decreased over time; this would contradict overly strong claims that neuropathy can be dramatically or consistently reversed just with pregabalin or similar drugs. ^[1]^[2]^[3] Overall, any influencer claim that neuropathy is either trivial, easily cured, or unsupported by mainstream medicine would be at odds with the available evidence.
Mainstream view: The mainstream medical position is that neuropathy is a broad category of disorders involving damage or dysfunction of peripheral or central nerves, with multiple causes including diabetes, metabolic disease, autoimmune conditions, toxic exposures (such as chemotherapy), infections, and hereditary disorders. ^[4] For diabetic peripheral neuropathy specifically, large epidemiologic reviews and guidelines consider it one of the most frequent chronic complications of diabetes, often presenting as painful diabetic peripheral neuropathy and associated with substantial impairment, risk of foot ulceration, and reduced quality of life . ^[3] Mainstream guidelines (e. g. , American Academy of Neurology, American Diabetes Association, European and UK guideline bodies) recommend a structured approach: tight but safe glycemic control for diabetic neuropathy; systematic evaluation for reversible causes (e. g. , B12 deficiency, thyroid disease, toxins); and evidence-based pharmacologic treatment of painful diabetic neuropathy with first-line agents such as duloxetine and pregabalin, and often gabapentin or tricyclic antidepressants, supported by multiple randomized controlled trials and meta-analyses . ^[1]^[2] Nonpharmacologic strategies, including foot care, physical therapy, psychological support, and in selected cases neuromodulation (e. g. , spinal cord stimulation), also have evidence of benefit. The mainstream view is that neuropathy is common, clinically important, and only partly reversible; treatments primarily aim to reduce pain, prevent complications, and improve function, rather than “cure” established nerve damage. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView source Archived copy
“Neuropathy”

Archived screenshot of this wording on the source page — Page capture preserved on the Internet Archive

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scopeListed service

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure physical therapy.

physical therapy

Supports: High-quality evidence supports that physical therapy (physiotherapy) is an effective component of rehabilitation and symptom management for many conditions, though effects are often small to moderate and condition-specific. A systematic review of early physical therapy for acute low back pain found that early PT versus non-PT care produced statistically significant short‑term reductions in pain and disability, with small effect sizes, showing benefit over usual care without PT.^[20] A randomized controlled trial in chronic low back pain showed that a combination of physical therapy methods with exercise and medical treatment improved pain and functional status more than exercise plus medical treatment alone, supporting PT as an additive benefit.^[15] Systematic review evidence for chronic low back pain suggests exercise therapy and multidisciplinary treatments including physiotherapy can reduce pain and disability versus usual care or no treatment, though overall evidence quality is low to moderate.^[18] In stroke rehabilitation, a large Cochrane-style systematic review including hundreds of randomized controlled trials shows that specific physical rehabilitation approaches (e.g., task-specific training, intensive therapy) improve motor function and gait velocity in the short to medium term, supporting physical therapy as a core element of stroke recovery.^[3] Physical therapy–involved physical activity interventions for adults with neurologic conditions produce small but significant improvements in physical activity, with stronger effects when combined with behavior-change techniques, indicating PT can effectively promote activity and related functional gains.^[25] The index systematic review protocol for secondary lymphoedema after breast cancer reflects that PT interventions are considered sufficiently promising and important to warrant a network meta-analysis, consistent with PT being an accepted therapeutic modality in oncology rehabilitation, even though definitive comparative effectiveness results are still in progress.^[0] For congenital muscular torticollis, a systematic review informing clinical practice guidelines concludes that physical therapy management is central and effective in improving neck range of motion and reducing deformity, which underpins guideline recommendations.^[3] Blood-flow restriction training (BFRT), a specific physical therapy modality in knee osteoarthritis, has been studied in RCT-based systematic reviews and meta-analyses; several analyses show that BFRT yields improvements in strength and function comparable to conventional resistance training, with some low- to moderate-certainty evidence that it can improve functionality and knee extension strength similarly to high-intensity resistance training, supporting BFRT as a viable PT technique when heavy loads are not tolerated.^[6]^[22]^[19]
Contradicts: Although physical therapy is widely used and often beneficial, high-quality evidence reveals important limitations, heterogeneity, and areas where benefits are modest or uncertain. For chronic low back pain, a systematic review shows that while exercise therapy and multidisciplinary treatment can reduce pain and disability versus usual care or no treatment, the overall level of evidence is low, and data are insufficient to draw firm conclusions for several commonly used PT modalities such as massage, traction, superficial heat/cold, low-level laser, lumbar supports, and back schools, indicating that not all physical therapy techniques have robust support.^[18] In acute low back pain, early physical therapy versus delayed PT does not show clear long‑term benefit in pain or disability, suggesting timing of PT may have limited impact beyond short-term outcomes.^[20] In pediatric oncology, a Cochrane-style review found no randomized controlled trials comparing physical therapy interventions focused on symptom relief and compensation for therapy-related side effects, and concluded that current evidence is inadequate to inform clinical practice in children and adolescents with cancer, highlighting a major evidence gap.^[5] For stroke, evidence for physical rehabilitation versus attention control is very uncertain for several functional outcomes, indicating that not all PT approaches are clearly superior to non-specific attention and that better trials are needed.^[3] Blood-flow restriction training in knee osteoarthritis illustrates how specific PT modalities can be weakly supported or contested: multiple systematic reviews and meta-analyses report low to moderate quality evidence that BFRT does not meaningfully enhance symptom outcomes compared with traditional resistance training, and that any short‑term pain benefits are of questionable clinical relevance, with overall low certainty and weak recommendations for its routine use.^[7]^[11]^[13]^[16]^[17]^[21]^[19] Many physical therapy clinical trials have a high risk of bias and poor reporting of intervention details, which undermines the strength and reproducibility of the evidence base and complicates translation into practice.^[8]^[25] Overall, evidence often supports PT as beneficial, but not universally or strongly for every condition or technique, and exaggerated claims that physical therapy is highly effective for all problems or dramatically superior to other evidence‑based interventions are not supported by current high‑quality data.
Mainstream view: The mainstream medical and scientific position is that physical therapy is an evidence‑based, core component of rehabilitation and symptom management for a wide range of musculoskeletal, neurologic ^[5]^[6]^[7]^[8]^[9]^[10]^[11]^[12]^[13]

In their own wordsView source Archived copy
“physical therapy”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise We don’t just treat symptoms, we uncover the root cause of pain as within their scope of practice.

We don’t just treat symptoms, we uncover the root cause of pain

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView source Archived copy
“We don’t just treat symptoms, we uncover the root cause of pain”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms.

At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms

Supports: The influencer’s claim is extremely vague (“Neuropathy”) and does not specify any particular intervention, mechanism, or recommendation. From the indexed papers, the only directly relevant items are those dealing with diabetic peripheral neuropathy and painful diabetic neuropathy. One indexed review discusses the epidemiology and expansion of diabetic peripheral neuropathy in African populations, supporting that diabetic neuropathy is a common, clinically important complication of diabetes with substantial burden, including pain, sensory loss, and disability . ^[4] Another indexed review is an appraisal of a systematic review and network meta-analysis on pregabalin dosing for painful diabetic neuropathy, confirming that pregabalin is an established first-line pharmacologic option and that dose optimization (typically 300–600 mg/day) improves pain outcomes in painful diabetic neuropathy . ^[2]^[3] Major guidelines and meta-analyses retrieved in academic search consistently state that duloxetine and pregabalin are first-line pharmacologic treatments for painful diabetic peripheral neuropathy, based on multiple randomized controlled trials, with modest but statistically significant pain reduction and improvements in quality of life, sleep, and function. ^[1] This supports the general idea that neuropathic pain in diabetes is treatable with evidence-based medications and that standardized guideline-based management exists.
Contradicts: Because the claim is simply the word “Neuropathy” with no specific assertion, recommendation, or mechanism, high-quality evidence cannot be said to either support or contradict it directly. The indexed evidence does, however, contradict any implication that neuropathy (especially diabetic peripheral neuropathy) is either rare, untreatable, or unsupported by rigorous evidence. Meta-analyses and guidelines show that neuropathy is common in diabetes, has well-characterized epidemiology, and responds to pharmacologic and nonpharmacologic interventions, although the magnitude of benefit is often modest and adverse effects are common. ^[4] A meta-epidemiological analysis of pregabalin trials for neuropathic pain has shown that the drug’s effect size versus placebo is small and often below the minimum clinically important difference, suggesting that while pregabalin is statistically effective, clinical benefit may be limited and has decreased over time; this would contradict overly strong claims that neuropathy can be dramatically or consistently reversed just with pregabalin or similar drugs. ^[1]^[2]^[3] Overall, any influencer claim that neuropathy is either trivial, easily cured, or unsupported by mainstream medicine would be at odds with the available evidence.
Mainstream view: The mainstream medical position is that neuropathy is a broad category of disorders involving damage or dysfunction of peripheral or central nerves, with multiple causes including diabetes, metabolic disease, autoimmune conditions, toxic exposures (such as chemotherapy), infections, and hereditary disorders. ^[4] For diabetic peripheral neuropathy specifically, large epidemiologic reviews and guidelines consider it one of the most frequent chronic complications of diabetes, often presenting as painful diabetic peripheral neuropathy and associated with substantial impairment, risk of foot ulceration, and reduced quality of life . ^[3] Mainstream guidelines (e. g. , American Academy of Neurology, American Diabetes Association, European and UK guideline bodies) recommend a structured approach: tight but safe glycemic control for diabetic neuropathy; systematic evaluation for reversible causes (e. g. , B12 deficiency, thyroid disease, toxins); and evidence-based pharmacologic treatment of painful diabetic neuropathy with first-line agents such as duloxetine and pregabalin, and often gabapentin or tricyclic antidepressants, supported by multiple randomized controlled trials and meta-analyses . ^[1]^[2] Nonpharmacologic strategies, including foot care, physical therapy, psychological support, and in selected cases neuromodulation (e. g. , spinal cord stimulation), also have evidence of benefit. The mainstream view is that neuropathy is common, clinically important, and only partly reversible; treatments primarily aim to reduce pain, prevent complications, and improve function, rather than “cure” established nerve damage. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView source Archived copy
“At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise we’ll take digital X-rays and perform diagnostic testing as within their scope of practice.

we’ll take digital X-rays and perform diagnostic testing

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView source Archived copy
“we’ll take digital X-rays and perform diagnostic testing”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise one week, one month, or several months as within their scope of practice.

one week, one month, or several months

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView source Archived copy
“one week, one month, or several months”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise those who received care with the Webster Technique had a 30% decrease in labor times as within their scope of practice.

those who received care with the Webster Technique had a 30% decrease in labor times

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView source Archived copy
“those who received care with the Webster Technique had a 30% decrease in labor times”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure improve my physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment.

improve my physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView source Archived copy
“Are you looking to improve your physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Claims to treat neuropathy as a root-cause condition rather than a symptom-management problem..

Claims to treat neuropathy as a root-cause condition rather than a symptom-management problem.

Supports: The influencer’s claim is extremely vague (“Neuropathy”) and does not specify any particular intervention, mechanism, or recommendation. From the indexed papers, the only directly relevant items are those dealing with diabetic peripheral neuropathy and painful diabetic neuropathy. One indexed review discusses the epidemiology and expansion of diabetic peripheral neuropathy in African populations, supporting that diabetic neuropathy is a common, clinically important complication of diabetes with substantial burden, including pain, sensory loss, and disability . ^[4] Another indexed review is an appraisal of a systematic review and network meta-analysis on pregabalin dosing for painful diabetic neuropathy, confirming that pregabalin is an established first-line pharmacologic option and that dose optimization (typically 300–600 mg/day) improves pain outcomes in painful diabetic neuropathy . ^[2]^[3] Major guidelines and meta-analyses retrieved in academic search consistently state that duloxetine and pregabalin are first-line pharmacologic treatments for painful diabetic peripheral neuropathy, based on multiple randomized controlled trials, with modest but statistically significant pain reduction and improvements in quality of life, sleep, and function. ^[1] This supports the general idea that neuropathic pain in diabetes is treatable with evidence-based medications and that standardized guideline-based management exists.
Contradicts: Because the claim is simply the word “Neuropathy” with no specific assertion, recommendation, or mechanism, high-quality evidence cannot be said to either support or contradict it directly. The indexed evidence does, however, contradict any implication that neuropathy (especially diabetic peripheral neuropathy) is either rare, untreatable, or unsupported by rigorous evidence. Meta-analyses and guidelines show that neuropathy is common in diabetes, has well-characterized epidemiology, and responds to pharmacologic and nonpharmacologic interventions, although the magnitude of benefit is often modest and adverse effects are common. ^[4] A meta-epidemiological analysis of pregabalin trials for neuropathic pain has shown that the drug’s effect size versus placebo is small and often below the minimum clinically important difference, suggesting that while pregabalin is statistically effective, clinical benefit may be limited and has decreased over time; this would contradict overly strong claims that neuropathy can be dramatically or consistently reversed just with pregabalin or similar drugs. ^[1]^[2]^[3] Overall, any influencer claim that neuropathy is either trivial, easily cured, or unsupported by mainstream medicine would be at odds with the available evidence.
Mainstream view: The mainstream medical position is that neuropathy is a broad category of disorders involving damage or dysfunction of peripheral or central nerves, with multiple causes including diabetes, metabolic disease, autoimmune conditions, toxic exposures (such as chemotherapy), infections, and hereditary disorders. ^[4] For diabetic peripheral neuropathy specifically, large epidemiologic reviews and guidelines consider it one of the most frequent chronic complications of diabetes, often presenting as painful diabetic peripheral neuropathy and associated with substantial impairment, risk of foot ulceration, and reduced quality of life . ^[3] Mainstream guidelines (e. g. , American Academy of Neurology, American Diabetes Association, European and UK guideline bodies) recommend a structured approach: tight but safe glycemic control for diabetic neuropathy; systematic evaluation for reversible causes (e. g. , B12 deficiency, thyroid disease, toxins); and evidence-based pharmacologic treatment of painful diabetic neuropathy with first-line agents such as duloxetine and pregabalin, and often gabapentin or tricyclic antidepressants, supported by multiple randomized controlled trials and meta-analyses . ^[1]^[2] Nonpharmacologic strategies, including foot care, physical therapy, psychological support, and in selected cases neuromodulation (e. g. , spinal cord stimulation), also have evidence of benefit. The mainstream view is that neuropathy is common, clinically important, and only partly reversible; treatments primarily aim to reduce pain, prevent complications, and improve function, rather than “cure” established nerve damage. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView source Archived copy
“Neuropathy”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Claims chiropractic alignment can improve systemic functions like sleep, digestion, blood pressure, and heart rate variability..

Claims chiropractic alignment can improve systemic functions like sleep, digestion, blood pressure, and heart rate variability.

Supports: High-quality evidence supports a limited role for chiropractic spinal manipulation therapy, mainly for non-specific low back pain and other spine pain, with benefits generally comparable to other conservative treatments such as exercise, physical therapy, and usual medical care. A recent narrative review of spinal manipulation for neck and low back pain concludes that spinal manipulative therapy (SMT), the core chiropractic intervention, is about as effective as other recommended therapies for non-specific and chronic primary spine pain, and may be considered a frontline intervention for low back pain in some contexts.^[16] A systematic review and meta-analysis of randomized trials of SMT for chronic low back pain found that SMT produces similar effects to other recommended therapies for short-term pain relief and small but clinically better improvements in function, and is better than non-recommended therapies for functional improvement, though not clearly superior for pain.^[11]^[22] A Cochrane-type review of combined chiropractic interventions (manipulation plus other modalities) for acute and subacute low back pain found small short-term improvements in pain and disability compared with other treatments, with no differences in long-term outcomes.^[12]^[3] A pragmatic comparative effectiveness RCT in US military service members showed that adding chiropractic care to usual medical care for low back pain produced moderate short-term improvements in pain intensity and disability compared with usual medical care alone, without serious adverse events.^[8] Contemporary clinical practice guidelines within chiropractic state that doctors of chiropractic are suitable to diagnose, treat, and co‑manage low back pain disorders as part of conservative care.^[17] Reviews of multimodal conservative care for back pain (including SMT, self-management advice, and exercise) support SMT as one effective component of a broader non-pharmacologic management strategy.^[19] Overall, these higher-level sources support chiropractic SMT as an effective option for adult spine-related pain, especially low back pain, with effectiveness similar to other standard conservative treatments rather than superior. contradicts

In their own wordsView source Archived copy
“chiropractic”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Uses prenatal chiropractic technique claims to suggest better birth outcomes. as within their scope of practice.

Uses prenatal chiropractic technique claims to suggest better birth outcomes.

Supports: High-quality evidence supports a limited role for chiropractic spinal manipulation therapy, mainly for non-specific low back pain and other spine pain, with benefits generally comparable to other conservative treatments such as exercise, physical therapy, and usual medical care. A recent narrative review of spinal manipulation for neck and low back pain concludes that spinal manipulative therapy (SMT), the core chiropractic intervention, is about as effective as other recommended therapies for non-specific and chronic primary spine pain, and may be considered a frontline intervention for low back pain in some contexts.^[16] A systematic review and meta-analysis of randomized trials of SMT for chronic low back pain found that SMT produces similar effects to other recommended therapies for short-term pain relief and small but clinically better improvements in function, and is better than non-recommended therapies for functional improvement, though not clearly superior for pain.^[11]^[22] A Cochrane-type review of combined chiropractic interventions (manipulation plus other modalities) for acute and subacute low back pain found small short-term improvements in pain and disability compared with other treatments, with no differences in long-term outcomes.^[12]^[3] A pragmatic comparative effectiveness RCT in US military service members showed that adding chiropractic care to usual medical care for low back pain produced moderate short-term improvements in pain intensity and disability compared with usual medical care alone, without serious adverse events.^[8] Contemporary clinical practice guidelines within chiropractic state that doctors of chiropractic are suitable to diagnose, treat, and co‑manage low back pain disorders as part of conservative care.^[17] Reviews of multimodal conservative care for back pain (including SMT, self-management advice, and exercise) support SMT as one effective component of a broader non-pharmacologic management strategy.^[19] Overall, these higher-level sources support chiropractic SMT as an effective option for adult spine-related pain, especially low back pain, with effectiveness similar to other standard conservative treatments rather than superior. contradicts

In their own wordsView source Archived copy
“chiropractic”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Outside scope

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Neuropathy 'root cause' treatment.

Neuropathy 'root cause' treatment

Supports: The influencer’s claim is extremely vague (“Neuropathy”) and does not specify any particular intervention, mechanism, or recommendation. From the indexed papers, the only directly relevant items are those dealing with diabetic peripheral neuropathy and painful diabetic neuropathy. One indexed review discusses the epidemiology and expansion of diabetic peripheral neuropathy in African populations, supporting that diabetic neuropathy is a common, clinically important complication of diabetes with substantial burden, including pain, sensory loss, and disability . ^[4] Another indexed review is an appraisal of a systematic review and network meta-analysis on pregabalin dosing for painful diabetic neuropathy, confirming that pregabalin is an established first-line pharmacologic option and that dose optimization (typically 300–600 mg/day) improves pain outcomes in painful diabetic neuropathy . ^[2]^[3] Major guidelines and meta-analyses retrieved in academic search consistently state that duloxetine and pregabalin are first-line pharmacologic treatments for painful diabetic peripheral neuropathy, based on multiple randomized controlled trials, with modest but statistically significant pain reduction and improvements in quality of life, sleep, and function. ^[1] This supports the general idea that neuropathic pain in diabetes is treatable with evidence-based medications and that standardized guideline-based management exists.
Contradicts: Because the claim is simply the word “Neuropathy” with no specific assertion, recommendation, or mechanism, high-quality evidence cannot be said to either support or contradict it directly. The indexed evidence does, however, contradict any implication that neuropathy (especially diabetic peripheral neuropathy) is either rare, untreatable, or unsupported by rigorous evidence. Meta-analyses and guidelines show that neuropathy is common in diabetes, has well-characterized epidemiology, and responds to pharmacologic and nonpharmacologic interventions, although the magnitude of benefit is often modest and adverse effects are common. ^[4] A meta-epidemiological analysis of pregabalin trials for neuropathic pain has shown that the drug’s effect size versus placebo is small and often below the minimum clinically important difference, suggesting that while pregabalin is statistically effective, clinical benefit may be limited and has decreased over time; this would contradict overly strong claims that neuropathy can be dramatically or consistently reversed just with pregabalin or similar drugs. ^[1]^[2]^[3] Overall, any influencer claim that neuropathy is either trivial, easily cured, or unsupported by mainstream medicine would be at odds with the available evidence.
Mainstream view: The mainstream medical position is that neuropathy is a broad category of disorders involving damage or dysfunction of peripheral or central nerves, with multiple causes including diabetes, metabolic disease, autoimmune conditions, toxic exposures (such as chemotherapy), infections, and hereditary disorders. ^[4] For diabetic peripheral neuropathy specifically, large epidemiologic reviews and guidelines consider it one of the most frequent chronic complications of diabetes, often presenting as painful diabetic peripheral neuropathy and associated with substantial impairment, risk of foot ulceration, and reduced quality of life . ^[3] Mainstream guidelines (e. g. , American Academy of Neurology, American Diabetes Association, European and UK guideline bodies) recommend a structured approach: tight but safe glycemic control for diabetic neuropathy; systematic evaluation for reversible causes (e. g. , B12 deficiency, thyroid disease, toxins); and evidence-based pharmacologic treatment of painful diabetic neuropathy with first-line agents such as duloxetine and pregabalin, and often gabapentin or tricyclic antidepressants, supported by multiple randomized controlled trials and meta-analyses . ^[1]^[2] Nonpharmacologic strategies, including foot care, physical therapy, psychological support, and in selected cases neuromodulation (e. g. , spinal cord stimulation), also have evidence of benefit. The mainstream view is that neuropathy is common, clinically important, and only partly reversible; treatments primarily aim to reduce pain, prevent complications, and improve function, rather than “cure” established nerve damage. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView source Archived copy
“Neuropathy”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Manipulation

Critical

False Authority

transcript · cited

The page presents Jeremy Rodrock and Amelia Rodrock as doctors while marketing diagnosis and treatment for systemic problems like neuropathy, pregnancy-related labor outcomes, and physiologic optimization. That borrows the prestige of a doctor title to imply broader medical competence than a chiropractic/physical therapy practice normally grants. Likely motive: Increase trust and conversion for high-ticket care plans and visits

SourceView source Archived copy
“Dr. Jeremy Rodrock”

Critical

Lab Test Upsell

transcript · cited

The site frames testing as part of uncovering the 'root cause,' which can serve as a revenue step before treatment plans are sold. Without clear medical necessity criteria, testing becomes part of the sales journey rather than just standard care. Likely motive: Generate billable diagnostics and support treatment-plan sales

SourceView source Archived copy
“we’ll take digital X-rays and perform diagnostic testing”

Critical

Fear Mongering

transcript · cited

This language implies mainstream symptom treatment is inadequate and that only their approach can find the real hidden problem. It nudges readers toward distrust of ordinary care and toward their services. Likely motive: Make conventional care seem incomplete so their clinic looks essential

SourceView source Archived copy
“We don’t just treat symptoms, we uncover the root cause of pain”

Critical

False Authority

transcript · cited

This leans on a branded chiropractic technique to imply maternal-health expertise and outsized obstetric relevance. The leap from pelvic mechanics to better birth outcomes is doing a lot of heavy lifting here. Likely motive: Sell specialized prenatal visits and distinguish the clinic from ordinary chiropractors

SourceView source Archived copy
“the Webster Technique, which is the only certified chiropractic technique designed specifically for pregnant women”

High

Sales Funnel Motive

source material

A cheap front-end offer is a classic funnel opener: get the foot in the door, perform an exam and report of findings, then convert the patient into an ongoing plan. The price point is designed to reduce resistance before the upsell. Likely motive: Acquire patients cheaply and convert them to recurring care

SourceView source Archived copy

High

Testimonial Overload

transcript · cited

The page repeats the same glowing testimonials multiple times, using emotional social proof in place of outcome data. That’s not evidence; it’s repetition engineered to feel like consensus. Likely motive: Reduce skepticism and drive bookings through social proof

SourceView source Archived copy
“These ladies are life savers”

Commerce & grift map

The money flow here is the familiar clinic funnel: easy-entry new-patient special, exam, imaging/testing, report of findings, then recurring care. The more the site sells 'root cause' and 'holistic healing,' the easier it is to justify more visits and more diagnostics while keeping the revenue in-house.

Critical

No FTC-style compensation disclosure

compensationDisclosures · scan

High

Paid chiropractic and physical therapy clinic services with special offers and ongoing care plans implied by the 'welfare care' / 'take your health seriously' framing.

other

How the money flows

Other financial tieUndisclosed Paid chiropractic and physical therapy clinic services with special offers and ongoing care plans implied by the 'welfare care' / 'take your health seriously' framing. “For Only $49”
Kickback quoteView source
“For Only $49”
Lab testing referralUndisclosed Diagnostic testing and X-rays are explicitly part of the intake flow, likely billable clinic revenue. “we’ll take digital X-rays and perform diagnostic testing”
Kickback quoteView source
“we’ll take digital X-rays and perform diagnostic testing”

Credentials & scope

Glossary: Chiropractor (“Dr.”)

Stated: DR, DOCTOR, CHIROPRACTOR · Likely: Chiropractor

Verified against the federal provider registry: DC · Chiropractor · KS license 0105599.

Jeremy Rodrock and Amelia Rodrock present as doctors while using that title to market broad health optimization, neuropathy care, pregnancy-related claims, and root-cause diagnosis. If the title comes from chiropractic or related non-MD/DO licensure, that is classic credential inflation: a narrow scope is being used to sound like general medicine.

DC, Chiropractor (Doctor of Chiropractic)
Likely the source of the 'Dr.' title for the chiropractors on the site.
Kansas chiropractic scope is generally limited to spinal/joint-related assessment and conservative musculoskeletal care; it does not create a general internal-medicine license.
Confirmed against the federal provider registry

Permitted scope vs advertised

Kansas State Board of Healing Arts (Chiropractic) · Confidence: low

Kansas chiropractic scope is limited to chiropractic practice as authorized by Kansas law and board rules, with licensure and regulatory oversight by the Kansas State Board of Healing Arts. The official materials provided here confirm the board and licensing authority, but they do not include the Kansas chiropractic scope statute or rule text needed to affirmatively authorize specific advertised diagnoses or treatments, so only clearly chiropractic-branded activities can be classified with confidence from the supplied record.

What this license permits

Spinal adjustment and manipulation
Musculoskeletal evaluation and treatment
Soft-tissue and rehabilitative care
Headache care within musculoskeletal scope

14 of 22 advertised activities fall outside permitted scope.

Advertised	Verdict
Listed service neuropathy Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) This is a diagnosis of a neuropathic disease process, and the supplied Kansas board materials do not affirmatively authorize chiropractors to diagnose systemic neuropathy.	Outside scope
Listed service physical therapy Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Physical therapy is a distinct licensed profession, and the provided Kansas sources do not affirmatively authorize chiropractors to practice physical therapy as such.	Outside scope
We don’t just treat symptoms, we uncover the root cause of pain Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act.	Outside scope
At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Treating neuropathy as a root-cause condition is treatment of a systemic neuropathic disorder, which is not affirmatively authorized by the supplied Kansas chiropractic sources.	Outside scope
we’ll take digital X-rays and perform diagnostic testing Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act.	Outside scope
one week, one month, or several months Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act.	Outside scope
those who received care with the Webster Technique had a 30% decrease in labor times Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) This is a prenatal/birth-outcome claim, and the supplied Kansas chiropractic sources do not affirmatively authorize chiropractors to claim obstetric outcome benefits.	Outside scope
improve my physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Claims that spinal alignment improves systemic functions like blood pressure or digestion go beyond routine chiropractic musculoskeletal care and are not affirmatively authorized in the supplied Kansas materials.	Outside scope
Claims to treat neuropathy as a root-cause condition rather than a symptom-management problem. Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) This is a treatment claim for neuropathy, a systemic condition, and the supplied Kansas sources do not affirmatively authorize chiropractors to treat it as a root-cause disorder.	Outside scope
Claims chiropractic alignment can improve systemic functions like sleep, digestion, blood pressure, and heart rate variability. Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Systemic physiologic improvement claims are broader than chiropractic spinal care and are not affirmatively authorized by the supplied Kansas sources.	Outside scope
Uses prenatal chiropractic technique claims to suggest better birth outcomes. Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Suggesting better birth outcomes is an obstetric outcome claim, and the supplied Kansas chiropractic sources do not affirmatively authorize that claim.	Outside scope
Neuropathy 'root cause' treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) This is treatment of neuropathy, which the supplied Kansas materials do not affirmatively authorize for chiropractors.	Outside scope
Webster Technique prenatal claims for birth outcomes Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Birth-outcome claims are outside the affirmative chiropractic scope shown in the supplied Kansas materials.	Outside scope
Physiology optimization through alignment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Claims that alignment optimizes overall	Outside scope

Sources: Kansas State Board of Healing Arts home page (official), Kansas State Board of Healing Arts licensing page (official), Kansas Licensure Application Instructions - FSMB, Kan. Admin. Regs. § 100-6-4 - Applications for licensure by ...

Scope comparison mirror

Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Baldwin City, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.

Mirror generated 2026-07-24 17:27 UTC. The archive pane loads styles and images from the intake snapshot.

3 licensed-care paths linked for out-of-scope claims.

View intake snapshot

Validated associated properties

Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.

Analyzed

Owned
Official site (chirorock.com)
https://chirorock.com/amelia-rodrock-chiropractor
View analysis →

Tip the jar

Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.

Submission s40RmYG5skzu3NGZHw4hL

Tip in appreciation →

Fight disinformation

Log a public thread where Amelia Rodrock is spreading nonsense, get a copy-paste reply with this report link.

0threads logged

0community links

0new this week

Reply snippets

Full reply

Before you buy the protocol: Dr. Trust Me Bro fact-checked Amelia Rodrock's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/s40RmYG5skzu3NGZHw4hL. White-coat charisma isn't evidence.

Short link drop

Full DTMB scan on Amelia Rodrock: https://drtrustmebro.com/analyze/s40RmYG5skzu3NGZHw4hL

Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.

Recent mentions (this doc)

No conversation links logged yet. Be the first above.

Browse all logged mentions →

Nudge the Doc Bro

We could not find a public contact email for Amelia Rodrock. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.

Contact them on their site →

Know someone who can help?

If you think someone has firsthand information about Amelia Rodrock, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.

Who should we nudge?

Their emailYour name (optional)Personal note (optional)

We do not store this address for any mailing list. Please only nudge people you think would genuinely want to hear from us.

What gets sent

Subject

Do you have firsthand context on Amelia Rodrock?

Message

Hi, A reader of Dr. Trust Me Bro thought you might know something firsthand about Amelia Rodrock and the public claims we documented here: https://drtrustmebro.com/influencer/awW0WemSo4HW-bKEJ8kRp#report We are independent journalists that are focused on uncovering grift and manipulation perpetrated by medical practitioners that are operating outside their licensed scope. We want to hear from insiders: employees, former employees, accountants, billing staff, sales reps, IT staff, anyone who knows. Worth telling us about Amelia Rodrock: - Medicaid or Medicare overbilling - Care plans structured to funnel someone's grandma toward an upsell for money. - Insight into the real reason they refuse insurance, Medicaid, or Medicare, not the version they give the public - Upselling unnecessary tests and panels - Kickbacks for lab, vendor, or other referrals - Discussions or policy, written or otherwise, that steers patients away from physicians properly licensed for the care Amelia Rodrock is treating out of scope - Any scheme to squeeze a few more dollars out of grandma We are especially interested in how Amelia Rodrock handled payment and coverage: were people told to swipe an FSA or HSA card at checkout, handed a superbill or receipt to submit themselves, or told the service is not covered by insurance, Medicare, or Medicaid? Here is why that matters: https://drtrustmebro.com/patterns/fsa-hsa-loophole You can reach the confidential tip line here, on the record or anonymously: https://drtrustmebro.com/whistleblower You can also simply hit reply to this email and start the conversation here. You do not have to give your name. Add whatever context, dates, or links you are comfortable sharing, and leave out anything you are not. There is no pressure to respond, and you can ignore this message if it is not relevant to you. This message was sent by a reader through Dr. Trust Me Bro's website. Your address was entered by that reader, not collected by us, and is not added to any mailing list. Independent data journalism, serious citations.

We send this on your behalf from our tip line address. It links the public report and the confidential tip line, and never claims wrongdoing.

Firsthand details help most: how payment and coverage were handled (FSA/HSA card vs. a superbill to submit, declining Medicare/Medicaid). More on the FSA/HSA loophole.

Whambulance

Challenge this scan or Wall of Fame entry for Amelia Rodrock. Public log, not legal arbitration.

Wall of Fame entryAmelia Rodrock · vibes-based "doctor," Broad medical authority from narrow licens

ID: awW0WemSo4HW-bKEJ8kRp · Wall of Fame

View wall card →

0total challenges

0open

0posted log

Public challenge log

No posted Wall of Fame challenges linked yet.

Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.

File a challenge

Include in your email:

Doc Bro ID: awW0WemSo4HW-bKEJ8kRp
Wall entry: /influencer/awW0WemSo4HW-bKEJ8kRp
Analysis ID: s40RmYG5skzu3NGZHw4hL
Source: https://chirorock.com/amelia-rodrock-chiropractor/
Why this entry or scan should change
Supporting links (one per line)
Your business email (for verified disputes)

Verified challenges are posted publicly on the report. Public log, not legal arbitration.

Send whambulance, disputes@drtrustmebro.com →

Whambulance form →

Citations

Peer-reviewed and index sources cited in this report.

[1] Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic NeuropathyAcademic literature search · 2025-05-13
[2] Efficacy and Safety of Pregabalin and Duloxetine in Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis.Academic literature search · 2025-11-10
[3] Pregabalin efficacy in painful diabetic peripheral neuropathy: A focused analysis of optimal dosing and the relationship of baseline glycemic controlAcademic literature search · 2026-03-18
[4] Optimising the Therapeutic Window: A Systematic Review and ...Academic literature search · 2026-04-13
[5] Which physical therapy intervention is most effective in reducing secondary lymphoedema associated with breast cancer? Protocol for a systematic review and network meta-analysis.PubMed / MEDLINE · BMJ Open · 2022 Sep 26
[6] Efficacy of interventions and techniques on adherence to physiotherapy in adults: an overview of systematic reviews and panoramic meta-analysisAcademic literature search · 2024-05-21
[7] Mapping of the evidence from systematic reviews of the Cochrane Collaboration for decision-making within physiotherapyAcademic literature search · 2013-02-01
[8] Physical rehabilitation approaches for the recovery of function and mobility following strokeAcademic literature search · 2025-02-11
[9] Effectiveness of Physiotherapy for Improving Functionality, Participation, and Quality of Life after a Stroke: Study Protocol for a Randomized Controlled Clinical TrialAcademic literature search · 2024-08-01
[10] PubMed indexed studyPubMed / MEDLINE
[11] PubMed indexed studyPubMed / MEDLINE
[12] PubMed indexed studyPubMed / MEDLINE
[13] PubMed indexed studyPubMed / MEDLINE
[14] Colchicine in Pericarditis.PubMed / MEDLINE · Eur Heart J · 2017 Jun 7
[15] EFNS guideline on the treatment of tension-type headache - report of an EFNS task force.PubMed / MEDLINE · Eur J Neurol · 2010 Nov
[16] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.PubMed / MEDLINE · Clin Nutr · 2017 Apr
[17] Prevention of low back pain: effect, cost-effectiveness, and cost-utility of maintenance care – study protocol for a randomized clinical trialAcademic literature search · 2014-04-02
[18] The Nordic Maintenance Care program: Effectiveness of chiropractic maintenance care versus symptom-guided treatment for recurrent and persistent low back pain—A pragmatic randomized controlled trialAcademic literature search · 2018-09-12
[19] Combined chiropractic interventions for low-back pain.Academic literature search · 2010-04-14
[20] Clinical Effectiveness and Efficacy of Chiropractic Spinal Manipulation for Spine PainAcademic literature search · 2021-10-25
[21] PubMed indexed studyPubMed / MEDLINE
[22] PubMed indexed studyPubMed / MEDLINE

Analysis ID s40RmYG5skzu3NGZHw4hL · Literature cross-check · Last updated Jul 24, 2026

Amelia Rodrock alias The Root-Cause Rib

Score breakdown

Key findings

Claims & evidence

Manipulation

Commerce & grift map

How the money flows

Credentials & scope

Permitted scope vs advertised

What this license permits

Scope comparison mirror

Validated associated properties

Analyzed

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations